SCHEMBL14073395

SCHEMBL14073395

CC1(C)c2cc(C(=O)c3ccc(C(F)(F)F)cc3)ccc2-c2cc3c(cc21)-c1ccc(C(=O)c2ccc(C(F)(F)F)cc2)cc1C3(C)C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SRD5A2 P31213 3/20 0.50
▸ PDK2 Q15119 3/20 0.48
▸ CYP2C8 P10632 1/20 0.43
▸ CES2 O00748 1/20 0.43
▸ CES1 P23141 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ EPHX2 P34913 2/20 0.41
▸ TTR P02766 1/20 0.40
▸ BACE1 P56817 1/20 0.40
▸ RARB P10826 1/20 0.39
▸ RARG P13631 1/20 0.39
▸ RXRA P19793 1/20 0.39
▸ RXRB P28702 1/20 0.39
▸ RXRG P48443 1/20 0.39
▸ NR4A1 P22736 1/20 0.39
▸ NR4A2 P43354 1/20 0.39
▸ NR4A3 Q92570 1/20 0.39
▸ SIRT1 Q96EB6 1/20 0.39
▸ BCL2L1 Q07817 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16419700 0.95 SRD5A2 (0.45) SRD5A2PDK2CYP2C8CES2CES1
SCHEMBL14073419 0.87 SIRT1 (0.54) SRD5A2PDK2NPC1RAB9ARARB
SCHEMBL14073390 0.83 PDK2 (0.44) PDK2CES2CES1NPC1RAB9A
SCHEMBL1637360 0.81 ALDH1A1 (0.53) SRD5A2PDK2CES2CES1RAB9A
SCHEMBL13045515 0.78 PDK2 (0.52) PDK2RARBRARGRXRARXRB
SCHEMBL20036916 0.78 PDK2 (0.41) PDK2CES2CES1NPC1RAB9A
SCHEMBL20036915 0.77 PDK2 (0.40) PDK2CES2CES1NPC1RAB9A
SCHEMBL648641 0.75 SRD5A2 (0.83) SRD5A2CYP2C8CES2CES1NPC1
SCHEMBL14073311 0.75 PDK2 (0.49) PDK2RARBRARGRXRARXRB
SCHEMBL14073388 0.75 CNR2 (0.50) PDK2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1883688-B1 COMPOUNDS FOR ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2018-04-11 — — EP disclosed
US-8852756-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2014-10-07 — — US disclosed
US-8852756-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2014-10-07 — — US disclosed
US-20080220285-A1 Derivatives of fused aromatic systems; sublimation stability; easy to purify due to better solubilty; easy reproducibility because do not form isomers; high efficiency and high stability on use in organic electroluminescent devices MERCK PATENT GMBH (DE) 2008-09-11 — — US disclosed
US-20080220285-A1 Derivatives of fused aromatic systems; sublimation stability; easy to purify due to better solubilty; easy reproducibility because do not form isomers; high efficiency and high stability on use in organic electroluminescent devices MERCK PATENT GMBH (DE) 2008-09-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080220285-A1 Derivatives of fused aromatic systems; sublimation stability; easy to purify due to better solubilty; easy reproducibility because do not form isomers; high efficiency and high stability on use in organic electroluminescent devices TYR, DDT, PAH SRD5A2 731/4885PDK2 519/4885CYP2C8 520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback